Little is known about the role of
nitric oxide in the pathophysiology of
spinal cord ischemia. We evaluated the effects of
nitric oxide synthase (NOS) inhibition by
N(G)-nitro-L-arginine-methyl ester (
L-NAME) in rabbits whose abdominal aorta was occluded for 20 min (Experiment 1) or 25 min (Experiment 2). In Experiment 1, the
L-NAME group (n = 6) received 3 mg/kg i.v.
L-NAME, followed by an i.v. infusion of 3 mg x kg(-1). h(-1) until 6 h after reperfusion.
Ischemia was induced 20 min after the start of
L-NAME. The
phenylephrine group (n = 6) received
phenylephrine to maintain comparable blood pressure. The control group (n = 6) received saline. In Experiment 2,
L-NAME (3 mg/kg i.v.
L-NAME, followed by an i.v. infusion of 3 mg x kg(-1). h(-1) until 6 h after reperfusion) and
phenylephrine groups (n = 6 each) were studied.
Ischemia was induced 100 min after the start of
L-NAME. Forty-eight hours after reperfusion, hindlimb motor function and histopathology of the spinal cord were examined. In Experiment 1,
L-NAME and
phenylephrine both improved neurologic outcome, with higher intraischemic blood pressures than saline. In Experiment 2,
L-NAME worsened the neurologic and histopathologic outcome compared with
phenylephrine. Attenuation of damage by
L-NAME in Experiment 1 may be attributable to an intraischemic blood pressure increase. The worse outcome with
L-NAME in Experiment 2 suggests that NOS inhibition exacerbates ischemic spinal cord damage.
IMPLICATIONS: